Preview Mode Links will not work in preview mode

Evidence Based Medicine presented by InpharmD™


Sep 11, 2020

An open-label, non-randomized, single-arm, Expanded Access Program (EAP) trial conducted to explore potential signals of efficacy of COVID-19 convalescent plasma.

Read more here: inpharmd.com/covid